Loading…

Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook

One of the major causes of death on the globe is cancer. It has remained a significant obstacle for current therapies and has not yet been effectively treated. Conventional treatment strategies available for cancer such as surgery, chemotherapy, radiation therapy etc. have severe adverse effects. Th...

Full description

Saved in:
Bibliographic Details
Published in:Heliyon 2023-06, Vol.9 (6), p.e16561, Article e16561
Main Authors: Gaikwad, Sachin S., Morade, Yogita Y., Kothule, Akshada M., Kshirsagar, Sanjay J., Laddha, Umesh D., Salunkhe, Kishor S.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153
cites cdi_FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153
container_end_page
container_issue 6
container_start_page e16561
container_title Heliyon
container_volume 9
creator Gaikwad, Sachin S.
Morade, Yogita Y.
Kothule, Akshada M.
Kshirsagar, Sanjay J.
Laddha, Umesh D.
Salunkhe, Kishor S.
description One of the major causes of death on the globe is cancer. It has remained a significant obstacle for current therapies and has not yet been effectively treated. Conventional treatment strategies available for cancer such as surgery, chemotherapy, radiation therapy etc. have severe adverse effects. The use of herbal active constituents in cancer treatment has tremendous potential to increase the effectiveness of conventional cancer therapy. Natural plant active components have been reported to have strong in vitro pharmacological activity but narrow in vivo absorption. In order to increase their bioavailability and absorption and get around the drawbacks and negative effects of traditional herbal extracts, Phytosomes are one of the growing nanotechnologies that can be used to improve the miscibility of bioactive phytoconstituents in lipid-rich barriers and overcome their poor bioavailability. Many novel drug delivery carriers are employed for targeted delivery of phytoconstituent at the site of action. Phytosomes are well-known biocompatible nanocarriers that can be employed to increase the solubility and permeability of phytopharmaceuticals among various novel drug delivery systems (NDDS). This review mainly focused on various conventional as well as novel approaches and various Nano carrier used in cancer therapies. Also comprising summary of the most recent research on the development and use of phytosomes as a better carrier for herbal constituents in the treatment of cancer. Additionally provides information about the formulation, characterization technique and mechanism of drug release from phytosome. Some of the major herbal active constituents made of phytosome which have shown proven anticancer activity are also studied. Finally, challenges and future perspective related to phytosome in cancer treatment are also discussed. [Display omitted]
doi_str_mv 10.1016/j.heliyon.2023.e16561
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10227328</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S2405844023037684</els_id><sourcerecordid>2821643109</sourcerecordid><originalsourceid>FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhq0K1FalPwHkI4cm-GPXa3NBVQW0UqVeaK-W4x0nDrt2sL2p8u9xlFDKCc1hRvLM-47nQeg9JXNKqPi0nq9g8LsY5owwPgcqWkFP0DlrSDuTTUPevKrP0GXOa0IIbaVQHT9FZ7xjgkhFztHTwxbS1sMzjg5vVrsScxwhYx9wSWCKD0tsTbCQPuPrfruvRgjlCtuVGQYIS8hX2IQeu6lMCXCcyhDjz3forTNDhstjvkCP377-uLmd3T98v7u5vp_ZRsgyU53s3IKrGq0TrAUiHSGm540SggL0amEVOCKgc4Y1kjecWtV0AK51jrb8An056G6mxQi9raslM-hN8qNJOx2N1_--BL_Sy7jVlDDWcSarwsejQoq_JshFjz5bGAYTIE5ZM8moqLZE1db20GpTzDmBe_GhRO-56LU-ctF7LvrApc59eL3ky9QfCn9_AfVUFUbS2Xqop-59Alt0H_1_LH4DwhejaQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2821643109</pqid></control><display><type>article</type><title>Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook</title><source>ScienceDirect®</source><source>PubMed Central</source><creator>Gaikwad, Sachin S. ; Morade, Yogita Y. ; Kothule, Akshada M. ; Kshirsagar, Sanjay J. ; Laddha, Umesh D. ; Salunkhe, Kishor S.</creator><creatorcontrib>Gaikwad, Sachin S. ; Morade, Yogita Y. ; Kothule, Akshada M. ; Kshirsagar, Sanjay J. ; Laddha, Umesh D. ; Salunkhe, Kishor S.</creatorcontrib><description>One of the major causes of death on the globe is cancer. It has remained a significant obstacle for current therapies and has not yet been effectively treated. Conventional treatment strategies available for cancer such as surgery, chemotherapy, radiation therapy etc. have severe adverse effects. The use of herbal active constituents in cancer treatment has tremendous potential to increase the effectiveness of conventional cancer therapy. Natural plant active components have been reported to have strong in vitro pharmacological activity but narrow in vivo absorption. In order to increase their bioavailability and absorption and get around the drawbacks and negative effects of traditional herbal extracts, Phytosomes are one of the growing nanotechnologies that can be used to improve the miscibility of bioactive phytoconstituents in lipid-rich barriers and overcome their poor bioavailability. Many novel drug delivery carriers are employed for targeted delivery of phytoconstituent at the site of action. Phytosomes are well-known biocompatible nanocarriers that can be employed to increase the solubility and permeability of phytopharmaceuticals among various novel drug delivery systems (NDDS). This review mainly focused on various conventional as well as novel approaches and various Nano carrier used in cancer therapies. Also comprising summary of the most recent research on the development and use of phytosomes as a better carrier for herbal constituents in the treatment of cancer. Additionally provides information about the formulation, characterization technique and mechanism of drug release from phytosome. Some of the major herbal active constituents made of phytosome which have shown proven anticancer activity are also studied. Finally, challenges and future perspective related to phytosome in cancer treatment are also discussed. [Display omitted]</description><identifier>ISSN: 2405-8440</identifier><identifier>EISSN: 2405-8440</identifier><identifier>DOI: 10.1016/j.heliyon.2023.e16561</identifier><identifier>PMID: 37260890</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Cancer therapies ; Herbal extract ; Nanocarrier ; Phytosomes ; Review ; Targeted drug delivery</subject><ispartof>Heliyon, 2023-06, Vol.9 (6), p.e16561, Article e16561</ispartof><rights>2023 The Authors</rights><rights>2023 The Authors.</rights><rights>2023 The Authors 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153</citedby><cites>FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153</cites><orcidid>0000-0002-7063-6640 ; 0000-0001-8910-1366</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10227328/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S2405844023037684$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,3547,27923,27924,45779,53790,53792</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37260890$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gaikwad, Sachin S.</creatorcontrib><creatorcontrib>Morade, Yogita Y.</creatorcontrib><creatorcontrib>Kothule, Akshada M.</creatorcontrib><creatorcontrib>Kshirsagar, Sanjay J.</creatorcontrib><creatorcontrib>Laddha, Umesh D.</creatorcontrib><creatorcontrib>Salunkhe, Kishor S.</creatorcontrib><title>Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook</title><title>Heliyon</title><addtitle>Heliyon</addtitle><description>One of the major causes of death on the globe is cancer. It has remained a significant obstacle for current therapies and has not yet been effectively treated. Conventional treatment strategies available for cancer such as surgery, chemotherapy, radiation therapy etc. have severe adverse effects. The use of herbal active constituents in cancer treatment has tremendous potential to increase the effectiveness of conventional cancer therapy. Natural plant active components have been reported to have strong in vitro pharmacological activity but narrow in vivo absorption. In order to increase their bioavailability and absorption and get around the drawbacks and negative effects of traditional herbal extracts, Phytosomes are one of the growing nanotechnologies that can be used to improve the miscibility of bioactive phytoconstituents in lipid-rich barriers and overcome their poor bioavailability. Many novel drug delivery carriers are employed for targeted delivery of phytoconstituent at the site of action. Phytosomes are well-known biocompatible nanocarriers that can be employed to increase the solubility and permeability of phytopharmaceuticals among various novel drug delivery systems (NDDS). This review mainly focused on various conventional as well as novel approaches and various Nano carrier used in cancer therapies. Also comprising summary of the most recent research on the development and use of phytosomes as a better carrier for herbal constituents in the treatment of cancer. Additionally provides information about the formulation, characterization technique and mechanism of drug release from phytosome. Some of the major herbal active constituents made of phytosome which have shown proven anticancer activity are also studied. Finally, challenges and future perspective related to phytosome in cancer treatment are also discussed. [Display omitted]</description><subject>Cancer therapies</subject><subject>Herbal extract</subject><subject>Nanocarrier</subject><subject>Phytosomes</subject><subject>Review</subject><subject>Targeted drug delivery</subject><issn>2405-8440</issn><issn>2405-8440</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkU1vEzEQhq0K1FalPwHkI4cm-GPXa3NBVQW0UqVeaK-W4x0nDrt2sL2p8u9xlFDKCc1hRvLM-47nQeg9JXNKqPi0nq9g8LsY5owwPgcqWkFP0DlrSDuTTUPevKrP0GXOa0IIbaVQHT9FZ7xjgkhFztHTwxbS1sMzjg5vVrsScxwhYx9wSWCKD0tsTbCQPuPrfruvRgjlCtuVGQYIS8hX2IQeu6lMCXCcyhDjz3forTNDhstjvkCP377-uLmd3T98v7u5vp_ZRsgyU53s3IKrGq0TrAUiHSGm540SggL0amEVOCKgc4Y1kjecWtV0AK51jrb8An056G6mxQi9raslM-hN8qNJOx2N1_--BL_Sy7jVlDDWcSarwsejQoq_JshFjz5bGAYTIE5ZM8moqLZE1db20GpTzDmBe_GhRO-56LU-ctF7LvrApc59eL3ky9QfCn9_AfVUFUbS2Xqop-59Alt0H_1_LH4DwhejaQ</recordid><startdate>20230601</startdate><enddate>20230601</enddate><creator>Gaikwad, Sachin S.</creator><creator>Morade, Yogita Y.</creator><creator>Kothule, Akshada M.</creator><creator>Kshirsagar, Sanjay J.</creator><creator>Laddha, Umesh D.</creator><creator>Salunkhe, Kishor S.</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>6I.</scope><scope>AAFTH</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-7063-6640</orcidid><orcidid>https://orcid.org/0000-0001-8910-1366</orcidid></search><sort><creationdate>20230601</creationdate><title>Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook</title><author>Gaikwad, Sachin S. ; Morade, Yogita Y. ; Kothule, Akshada M. ; Kshirsagar, Sanjay J. ; Laddha, Umesh D. ; Salunkhe, Kishor S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Cancer therapies</topic><topic>Herbal extract</topic><topic>Nanocarrier</topic><topic>Phytosomes</topic><topic>Review</topic><topic>Targeted drug delivery</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gaikwad, Sachin S.</creatorcontrib><creatorcontrib>Morade, Yogita Y.</creatorcontrib><creatorcontrib>Kothule, Akshada M.</creatorcontrib><creatorcontrib>Kshirsagar, Sanjay J.</creatorcontrib><creatorcontrib>Laddha, Umesh D.</creatorcontrib><creatorcontrib>Salunkhe, Kishor S.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Heliyon</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gaikwad, Sachin S.</au><au>Morade, Yogita Y.</au><au>Kothule, Akshada M.</au><au>Kshirsagar, Sanjay J.</au><au>Laddha, Umesh D.</au><au>Salunkhe, Kishor S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook</atitle><jtitle>Heliyon</jtitle><addtitle>Heliyon</addtitle><date>2023-06-01</date><risdate>2023</risdate><volume>9</volume><issue>6</issue><spage>e16561</spage><pages>e16561-</pages><artnum>e16561</artnum><issn>2405-8440</issn><eissn>2405-8440</eissn><abstract>One of the major causes of death on the globe is cancer. It has remained a significant obstacle for current therapies and has not yet been effectively treated. Conventional treatment strategies available for cancer such as surgery, chemotherapy, radiation therapy etc. have severe adverse effects. The use of herbal active constituents in cancer treatment has tremendous potential to increase the effectiveness of conventional cancer therapy. Natural plant active components have been reported to have strong in vitro pharmacological activity but narrow in vivo absorption. In order to increase their bioavailability and absorption and get around the drawbacks and negative effects of traditional herbal extracts, Phytosomes are one of the growing nanotechnologies that can be used to improve the miscibility of bioactive phytoconstituents in lipid-rich barriers and overcome their poor bioavailability. Many novel drug delivery carriers are employed for targeted delivery of phytoconstituent at the site of action. Phytosomes are well-known biocompatible nanocarriers that can be employed to increase the solubility and permeability of phytopharmaceuticals among various novel drug delivery systems (NDDS). This review mainly focused on various conventional as well as novel approaches and various Nano carrier used in cancer therapies. Also comprising summary of the most recent research on the development and use of phytosomes as a better carrier for herbal constituents in the treatment of cancer. Additionally provides information about the formulation, characterization technique and mechanism of drug release from phytosome. Some of the major herbal active constituents made of phytosome which have shown proven anticancer activity are also studied. Finally, challenges and future perspective related to phytosome in cancer treatment are also discussed. [Display omitted]</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>37260890</pmid><doi>10.1016/j.heliyon.2023.e16561</doi><orcidid>https://orcid.org/0000-0002-7063-6640</orcidid><orcidid>https://orcid.org/0000-0001-8910-1366</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2405-8440
ispartof Heliyon, 2023-06, Vol.9 (6), p.e16561, Article e16561
issn 2405-8440
2405-8440
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10227328
source ScienceDirect®; PubMed Central
subjects Cancer therapies
Herbal extract
Nanocarrier
Phytosomes
Review
Targeted drug delivery
title Overview of phytosomes in treating cancer: Advancement, challenges, and future outlook
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T13%3A13%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Overview%20of%20phytosomes%20in%20treating%20cancer:%20Advancement,%20challenges,%20and%20future%20outlook&rft.jtitle=Heliyon&rft.au=Gaikwad,%20Sachin%20S.&rft.date=2023-06-01&rft.volume=9&rft.issue=6&rft.spage=e16561&rft.pages=e16561-&rft.artnum=e16561&rft.issn=2405-8440&rft.eissn=2405-8440&rft_id=info:doi/10.1016/j.heliyon.2023.e16561&rft_dat=%3Cproquest_pubme%3E2821643109%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c468t-9787fb393935f625e08f00ad349661eed9bc9ef06e7fa2483431c947eef5ff153%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2821643109&rft_id=info:pmid/37260890&rfr_iscdi=true